Targeted  metabolism Metabolic targets  Agents References
Glycolysis GLUT1
HKII
PGAM
PKM2
LDHA
Transketolase     G6PD 
 MCT1
Fasentin:  WZB117: Diclofenac
2-deoxyglucose: 3-bromopyruvate: lonidamine: metformin: cerulenin
MJE3
TLN-232 (or CAP-232)
FX11: Diclofenac
Oxythiamine
6-Aminonicotinamide (6-AN)
Diclofenac
[52-54]
[18-23]
[50]
[30]
[39-40: 58-59]
[46-47]       
[48-49]
[58-59]
Glutamine Glutaminase Glutamine ASCT2 (SLC1A5) SLC7A5/SLC3A2 Compand 968
Phenylacetate
L-γ-glutamyl-p-nitroanilide (GPNA)
2-aminobicyclo-(2:2:1) heptanecarboxylic acid(BCH)
[3]
[65-66]
[82]
[83]
Citric acid Master regulators PDK Mutant IDH HIF1α AKT Dichloroacetate
Antibody MsMab-1: AGI-5198:
KC7F2: RX-0047
MK-2206                                                               
[55-57]
[145-146]
[76-77] [86]
GLUT1: Glucose Transporter 1; HKII: Hexokinase II; PGAM1: Phosphoglycerate Mutase 1; PKM2: Pyruvate Kinase Muscle Isozyme 2; LDHA: Lactate Dehydrogenase A; G6PD: Glucose-6-Phosphate Dehydrogenase; MCT1: Monocarboxylate Transporter 1; ASCT2: Solute Carrier Family 1 (Neutral Amino Acid Transporter): Member 5 (also called SLC1A5); SLC7A5: Solute Carrier Family 7 (Amino Acid Transporter Light Chain: l system): Member 5; SLC3A2: Solute Carrier Family 3 (Amino Acid Transporter Heavy Chain) member 2; PDK: Pyruvate Dehydrogenase Kinase; IDH: Isocitrate Dehydrogenase; HIF1: Hypoxia Inducible Factor 1; Alpha Subunit (basic helix-loop-helix transcription factor); AKT: v-akt Murine Thymoma Viral Oncogene Homolog
Table 1: Targeting glucose/glutamine metabolism for cancer therapy.